On Monday 15 April, Medicines for Europe (the drug industry) recommended measures to facilitate the reallocation of stocks of medicines from one EU country to another.
According to the organisation, some EU Member States (France, Germany, the Czech Republic, Austria, Greece, Denmark and Poland) are increasingly asking medicine manufacturers to stockpile, “undermining EU solidarity and exacerbating the risk of shortages”.
Stockpiling mandates “prevent manufacturers from reallocating...